Stockreport

Is Takeda's Upgraded FY2025 Outlook And New PID Therapy Altering The Investment Case For Takeda (TSE:4502)? [Yahoo! Finance]

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK) 
PDF billions, alongside slightly higher earnings per share year-on-year, and raised its full-year 2025 revenue and profit guidance. Takeda also announced U.S. availability [Read more]